Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2476-2486
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2476
Table 4 Univariate and multivariate Cox proportional hazards model for recurrence-free survival and overall survival
VariableUnivariate analysis
Multivariate analysis
Total, n
HR
95%CI
P value
HR
95%CI
P value
RFS
    Pre-LT DEB-TACE as yes/no45/542.621.41-4.890.0022.731.44-5.140.002
Child-Pugh classification
    A83ReferenceN/AN/AN/AN/AN/A
    B122.030.98-4.230.056N/AN/AN/A
    C41.520.36-6.350.559N/AN/AN/A
Macrovascular invasion as yes/no31/681.740.98-3.090.056N/AN/AN/A
Overall diameter of target (tumors in cm for ≤ 7 cm/> 7 cm)46/532.551.38-4.690.0031.981.05-3.750.035
AFP of ≤ 400 ng/mL/> 400 ng/mL)74/252.341.30-4.190.0042.271.23-4.210.009
Tumor differentiation
    Well differentiated3ReferenceN/AN/AN/AN/AN/A
    Moderately differentiated711.420.19-10.450.726N/AN/AN/A
    Undifferentiated252.270.30-17.130.426N/AN/AN/A
OS
    Pre-LT DEB-TACE as yes/no45/543.331.51-7.340.0033.151.43-6.960.004
Child-Pugh classification
    A83ReferenceN/AN/AN/AN/AN/A
    B122.461.06-5.680.035N/AN/AN/A
    C41.810.42-7.660.41N/AN/AN/A
Macrovascular invasion as yes/no31/68 1.250.62-2.480.524N/AN/AN/A
Overall diameter of target (tumors in cm of ≤ 7 cm/> 7 cm)46/532.091.02-4.280.042N/AN/AN/A
AFP of ≤ 400 ng/mL/> 400 ng/mL74/251.680.83-3.390.145N/AN/AN/A
Tumor differentiation
    Well differentiated3ReferenceN/AN/AN/AN/AN/A
    Moderately differentiated71N/ANA10.922N/AN/AN/A
    Undifferentiated25N/ANA10.920N/AN/AN/A